Results 1 to 10 of about 136,208 (293)

The basal ganglia [PDF]

open access: bronzeTrends in Neurosciences, 2000
Augood SJ, Penney JB Jr, Friberg IK, Breakefield XO, Young AB, Ozelius LJ, Standaert DG: Expression of the early-onset torsion dystonia gene (DYT1) in human brain.Ann Neurol 1998, 43:669-673.Bejjani BP, Damier P, Arnulf I, Thivard L, Bonnet AM, Dormont D, Cornu P, Pidoux B, Samson Y, Agid Y.
Ann M. Graybiel
  +10 more sources

Germinoma of basal ganglia

open access: yesRadiology Case Reports
Basal ganglia germinomas (BGGs) are rare lesions. Because of the atypical features of early-stage clinical symptoms and imaging characteristics, BGGs are easily misdiagnosed with non-tumorous conditions.
Ho Xuan Tuan, MD, PhD   +6 more
doaj   +3 more sources

Ropinirole Cotreatment Prevents Perivascular Glial Recruitment in a Rat Model of L-DOPA-Induced Dyskinesia

open access: yesCells, 2023
Dopamine replacement therapy for Parkinson’s disease is achieved using L-DOPA or dopamine D2/3 agonists, such as ropinirole. Here, we compare the effects of L-DOPA and ropinirole, alone or in combination, on patterns of glial and microvascular reactivity
Osama F. Elabi   +4 more
doaj   +1 more source

Distinct patterns of dyskinetic and dystonic features following D1 or D2 receptor stimulation in a mouse model of parkinsonism

open access: yesNeurobiology of Disease, 2021
L-DOPA-induced dyskinesia (LID) is a significant complication of dopamine replacement therapy in Parkinson's disease (PD), and the specific role of different dopamine receptors in this disorder is poorly understood.
Laura Andreoli   +3 more
doaj   +1 more source

Motor symptom asymmetry predicts non-motor outcome and quality of life following STN DBS in Parkinson's disease

open access: yesScientific Reports, 2022
Risk factors for long-term non-motor symptoms and quality of life following subthalamic nucleus deep brain stimulation (STN DBS) have not yet been fully identified.
Philippe Voruz   +8 more
doaj   +1 more source

Emotions and cognitive control: A comparison of bipolar disorder and schizophrenia

open access: yesJournal of Affective Disorders Reports, 2021
Background: Bipolar disorder (BP) and schizophrenia (SZ) are both psychiatric conditions characterized by deficits in cognitive control (executive function and attention) and emotion regulation. The emotional Stroop task makes it possible to measure such
Murielle Sollier-Guillery   +6 more
doaj   +1 more source

APOE ε4 allele, along with G206D-PSEN1 mutation, alters mitochondrial networks and their degradation in Alzheimer’s disease

open access: yesFrontiers in Aging Neuroscience, 2023
IntroductionAlzheimer’s disease remains the most common neurodegenerative disorder, depicted mainly by memory loss and the presence in the brain of senile plaques and neurofibrillary tangles.
Irene Costa-Laparra   +8 more
doaj   +1 more source

Basal ganglia calcification [PDF]

open access: yesBMJ Case Reports, 2013
A 65-year-old man presented to the emergency room after a fall, sustaining a head injury. A CT of the head showed diffuse, symmetric parenchymal calcifications involving the thalami globus palladi and caudate heads (figures 1 and 2). Detailed evaluation revealed a long-standing history of muscle cramps, involuntary choreiform movements and gradual ...
Rushad Patell   +3 more
openaire   +3 more sources

The basal ganglia and apraxia [PDF]

open access: yesBrain, 1996
Ever since Liepmann's original descriptions at the beginning of the century apraxia has usually been attributed to damage confined to the cerebral cortex and/or cortico-cortical connecting pathways. However, there have been suggestions that apraxia can be due to deep subcortical lesions, which raises the question as to whether damage to the basal ...
Peter P. Pramstaller, C. David Marsden
openaire   +3 more sources

Spatio-temporal dynamics of large-scale electrophysiological networks during cognitive action control in healthy controls and Parkinson's disease patients

open access: yesNeuroImage, 2022
Among the cognitive symptoms that are associated with Parkinson's disease (PD), alterations in cognitive action control (CAC) are commonly reported in patients. CAC enables the suppression of an automatic action, in favor of a goal-directed one.
Joan Duprez   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy